Why the Amcor Limited share price is getting smoked

Amcor Limited (ASX:AMC) might not pass many ethical investing screens.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

Shares in Amcor Limited (ASX: AMC) have fallen nearly 8% from $15.28 to $14.16 today after the packaging giant returned to the ASX boards from a trading halt imposed on news it is to acquire U.S. rival Bemis Inc for an upfront 25% premium.

Amcor will offer 5.1 shares for every 1 Bemis share with shareholders owning 71% and 29% respectively of the combined company.

However, it seems Amcor shares got ahead of themselves in the week prior to the news becoming official, with Bemis shares also spiking over the NYSE-trading-day prior to the deal's announcement.

Speculators who got wind of the giant US$6.8 billion deal and hoped to make a cheeky profit may even be underwater looking at the below chart.

Chart: Amcor share price over past 1 month (Source Google Finance).

While some investors would consider coal miners like Whitehaven Coal Ltd (ASX: WHC) or pokie machine manufacturers like Aristocrat Leisure Limited (ASX: ALL) as among Australia's least ethical companies due to their downstream impact on society, it's fair to say Amcor's place as a leading manufacturer of cigarette packets makes it a strong contender on the unethical front.

The combined Amcor Bemis group will have pro forma EBITDA of US$2.2 billion on revenues of US$13 billion and expects to be able to make pre-tax cost savings of US$180 million per year by year three as a result of the deal.

The move to de-list from the ASX should come as no surprise to Amcor investors given it already reports in U.S. dollar with the majority of its operations overseas.

If Amcor's ethics aren't your cup of tea, why not read on about a company growing like nuts while providing innovative healthcare services….

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man looking at his laptop and thinking.
Materials Shares

Core Lithium shares tumble after $120m capital raising for Finniss restart

It won't be long until the company is producing lithium again.

Read more »

A stopwatch ticking close to the 12 where the words on the face say 'Time to Buy'.
Cheap Shares

3 quality ASX shares to buy and hold until 2036

These aren’t struggling stocks and brokers remain highly bullish.

Read more »

A businesswoman exhales a deep sigh after receiving bad news, and gets on with it.
Share Market News

5 things to watch on the ASX 200 on Thursday

It looks set to be a tough session for Aussie investors today.

Read more »

Three young people in business attire sit around a desk and discuss.
Opinions

Top 3 ASX 200 shares I'd buy today with $12,000

These are the shares I'd be buying right now.

Read more »

A young boy reaches up to touch the raindrops on his umbrella, as the sun comes out in the sky behind him.
Share Market News

Why these ASX shares could be buys in today's volatile market

This solid trio could help investors earn income and weather uncertainty.

Read more »

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy hump day session for the ASX.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Scientists working in the laboratory and examining results.
Opinions

3 reasons to buy CSL shares today

The ASX biotech company has great growth potential this year.

Read more »